期刊文献+

HPLC法测定奥沙利铂脂质体中奥沙利铂的含量 被引量:6

Content Determination of Oxaliplatin in Oxaliplatin Liposome by HPLC
原文传递
导出
摘要 目的:建立以高效液相色谱法测定奥沙利铂脂质体中奥沙利铂含量的方法。方法:色谱柱为Hypersil C18(250 mm×4.6mm,5μm),流动相为甲醇:水=5∶95(V/V),流速为1.0 mL·min-1,检测波长为250 nm,柱温为30℃。结果:奥沙利铂的检测浓度在12.2~122.0μg·mL-1范围内线性关系良好;以峰面积(Y)为对浓度(C)进行回归分析,得回归方程为Y=78 575 C-4 811.8(n=5,r=0.999 9),奥沙利铂的检测浓度在12.2~122.0μg·mL-1范围内线性关系良好;检测限为97.6 ng·mL-1;平均回收率为98.58%,RSD=1.83%。结论:该方法操作简便、灵敏、准确,可用于奥沙利铂脂质体中奥沙利铂的含量测定。 OBJECTIVE:To establish an HPLC method for the content determination of oxaliplatin in Oxaliplatin liposome. METHODS:The separation was performed on Hypersil C18(250 mm×4.6 mm,5 μm) column with methanol-water(5 ∶ 95,V/V) as mobile phase at flow rate of 1.0 mL·min^-1. The detection wavelength was set at 250 nm and column temperature was 30 ℃. RESULTS:The linear range of oxaliplatin was 12.2~122.0 μg.mL^-1(n=5,r=0.999 9) with an average recovery of 98.58%(RSD=1.83%). The limit of detection(LOD) was 97.6 ng·mL^-1. CONCLUSION:The method is simple,sensitive and accurate for the content determination of oxaliplatin in Oxaliplatin liposome.
出处 《中国药房》 CAS CSCD 北大核心 2010年第32期3058-3060,共3页 China Pharmacy
关键词 奥沙利铂 脂质体 高效液相色谱法 含量 Oxaliplatin Liposome HPLC Content
  • 相关文献

参考文献12

  • 1Mathe G, Kidani Y, Segiguchi M, et al. Oxalato-platinum or 1-OHP a third-generation paltinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum[J]. Biomed Pharmacother, 1989,43(4) : 237.
  • 2Bokemeyer C, Bondarenko I, Makhson A, et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer[J]. J Clin Oncol, 2009,27 (5) : 655.
  • 3Zhu AX, Blaszkowshy LS, Ryan DP, et al. Phase lI study of gemcitabine and oxaliplatin in combination with bevacizumab in patiens with advanced hepatocellular carcinoma[J]. J Clin Oncol, 2006,24 ( 12 ) : 1 898.
  • 4Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer[J]. N EnglJMed, 2008,358( 1 ) : 36.
  • 5Tredaniel J, Becht C, Bekradda M, et al. An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients[J]. Lung Cancer, 2009,63 (2) : 259.
  • 6董虹亮,梁建群.奥沙利铂联合紫杉醇、5-氟尿嘧啶治疗中晚期大肠癌的临床观察[J].中国药房,2008,19(20):1568-1570. 被引量:5
  • 7Chang CC, Liu DZ, Lin SY, et al. Liposome encapsulation reduces cantharidin toxicity[J]. Food Chem Toxicol, 2008,46(9):3 116.
  • 8Wenzel J, Zeisig R, Fichtner I. Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation[J]. IntJPharm,2009,370(1-2) : 121.
  • 9刘小平,耿丹清,石炳光,曹华.奥沙利铂脂质体中奥沙利铂的含量测定[J].中国医药导报,2007,4(09S):101-102. 被引量:5
  • 10李军依,韩加怡.反相高效液相色谱法测定奥沙利铂含量及相关杂质[J].医药导报,2008,27(5):597-598. 被引量:10

二级参考文献19

共引文献31

同被引文献47

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部